Jiezhen Mo

Publication Activity (10 Years)

Years Active: 2020-2024
Publications (10 Years): 6

Top Topics

Gene Expression

Circulating Tumor

Top Venues

Analytical chemistry

Nature communications

This page only lists publications with an associated author ORCID identifier.

Publications

Jiezhen Mo, Fredrik Wermeling, Gunnar P Nilsson, Joakim S Dahlin
CRISPR/Cas9-mediated gene disruption determines the roles of MITF and CITED2 in human mast cell differentiation. Blood advances 8 (15) (2024)
Jiezhen Mo, Fredrik Wermeling, Gunnar P Nilsson, Joakim S Dahlin
CRISPR/Cas9-mediated gene disruption determines the roles of MITF and CITED2 in human mast cell differentiation. Blood advances 8 (15) (2024)
Jiezhen Mo, Fredrik Wermeling, Gunnar P Nilsson, Joakim S Dahlin
CRISPR/Cas9-mediated gene disruption determines the roles of MITF and CITED2 in human mast cell differentiation. Blood advances 8 (15) (2024)
Jiezhen Mo, Fredrik Wermeling, Gunnar P Nilsson, Joakim S Dahlin
CRISPR/Cas9-mediated gene disruption determines the roles of MITF and CITED2 in human mast cell differentiation. Blood advances (2024)
Qiang Luo, Jiezhen Mo, Hao Chen, Zetao Hu, Baihui Wang, Jiabing Wu, Ziyu Liang, Wenhao Xie, Kangxi Du, Maolin Peng, Yingping Li, Tianyang Li, Yangyi Zhang, Xiaoyan Shi, Wen-Hui Shen, Yang Shi, Aiwu Dong, Hai-Lin Wang, Jinbiao Ma
Structural insights into molecular mechanism for N 6 -adenosine methylation by MT-A70 family methyltransferase METTL4. Nature communications 13 (1) (2022)
Jiezhen Mo, Ziyu Liang, Meiling Lu, Hai-Lin Wang
Protonation-Suppression-Free LC-MS/MS Analysis for Profiling of DNA Cytosine Modifications in Adult Mice. Analytical chemistry 92 (11) (2020)